| 摘要 |
<p>Combinations of (2R, c^_i_^_s^_)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one or a pharmaceutically acceptable derivative thereof and a non-nucleoside inhibitor of HIV selected from a {[(benzoxazol-2-yl)methyl]amino}-5-alkyl-6-alkyl-2-(1H)-pyridinone or a derivative thereof bearing an unsubstituted or substituted pyridyl or phenyl substituent, pharmaceutical formulations of such combinations and the use of such combinations and formulations to treat viral infections, in particular HIV infections, are described.</p> |
